SCHEMBL12470988

SCHEMBL12470988

CCOC(=O)C1CCN(Cc2ccc3cc(OC4CCC4)ccc3c2)CC1

nearest known ligand 0.72

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.61
ALDH1A1 P00352 6/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
MAPT P10636 1/20 0.59
CCR8 P51685 1/20 0.57
HRH3 Q9Y5N1 1/20 0.57
KMT2A Q03164 2/20 0.53
POLB P06746 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
GAA P10253 1/20 0.52
PKM P14618 1/20 0.52
HTT P42858 1/20 0.52
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12472388 0.98 KDM4E (0.61) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471022 0.97 KDM4E (0.60) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471430 0.97 KDM4E (0.60) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL17053647 0.93 KDM4E (0.60) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471514 0.92 KDM4E (0.55) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471205 0.92 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471201 0.92 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471506 0.92 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12687661 0.92 KDM4E (0.59) KDM4EALDH1A1SMN1; SMN2MAPTCCR8
SCHEMBL12471899 0.91 KDM4E (0.61) KDM4EALDH1A1SMN1; SMN2MAPTCCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10894040-B2 S1P modulating agents BIOGEN MA INC. (US) 2021-01-19 US disclosed
US-10894040-B2 S1P modulating agents BIOGEN MA INC. (US) 2021-01-19 US disclosed
EP-3660010-A1 S1P MODULATING AGENTS Biogen MA Inc. (US) 2020-06-03 EP disclosed
EP-3660010-A1 S1P MODULATING AGENTS Biogen MA Inc. (US) 2020-06-03 EP disclosed
US-20200038385-A1 S1P MODULATING AGENTS BIOGEN IDEC MA INC. 2020-02-06 US disclosed
US-20200038385-A1 S1P MODULATING AGENTS BIOGEN IDEC MA INC. 2020-02-06 US disclosed
EP-3150590-B1 S1P MODULATING AGENTS BIOGEN MA INC (US) 2019-10-16 EP disclosed
EP-3150590-B1 S1P MODULATING AGENTS BIOGEN MA INC (US) 2019-10-16 EP disclosed
US-10406144-B2 SIP modulating agents BIOGEN MA INC. (US) 2019-09-10 US disclosed
US-10406144-B2 SIP modulating agents BIOGEN MA INC. (US) 2019-09-10 US disclosed
EP-2672823-B1 S1P MODULATING AGENTS BIOGEN MA INC (US) 2016-08-24 EP disclosed
US-9340527-B2 S1P modulating agents BIOGEN MA INC. (US) 2016-05-17 US disclosed
US-9340527-B2 S1P modulating agents BIOGEN MA INC. (US) 2016-05-17 US disclosed
US-9340527-B2 S1P modulating agents BIOGEN MA INC. (US) 2016-05-17 US disclosed
US-20140371209-A1 S1P Modulating Agents BIOGEN MA INC. 2014-12-18 US disclosed
US-20140371209-A1 S1P Modulating Agents BIOGEN MA INC. 2014-12-18 US disclosed
US-20140371209-A1 S1P Modulating Agents BIOGEN MA INC. 2014-12-18 US disclosed
EP-2672823-A1 S1P MODULATING AGENTS Biogen Idec MA Inc. (US) 2013-12-18 EP disclosed
WO-2012109108-A1 S1P MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2012-08-16 WO disclosed
WO-2012109108-A1 S1P MODULATING AGENTS BIOGEN IDEC MA INC. (US) 2012-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200038385-A1 S1P MODULATING AGENTS S1PR2, S1PR1, S1PR3 KDM4E 3037/4885ALDH1A1 2452/4885SMN1; SMN2 3024/4885
US-20140371209-A1 S1P Modulating Agents S1PR2, S1PR1, S1PR3 KDM4E 3804/4885ALDH1A1 2436/4885SMN1; SMN2 1805/4885
US-10406144-B2 SIP modulating agents S1PR2, S1PR1, S1PR3 KDM4E 3487/4885ALDH1A1 2802/4885SMN1; SMN2 1975/4885
US-10894040-B2 S1P modulating agents S1PR2, S1PR1, S1PR3 KDM4E 2656/4885ALDH1A1 2508/4885SMN1; SMN2 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.